|
CCDC97 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.523800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.453600E-02 |
| Normal-vs-Stage2 |
8.484300E-02 |
| Normal-vs-Stage3 |
9.215800E-02 |
| Normal-vs-Stage4 |
4.470200E-02 |
| Stage1-vs-Stage2 |
4.177800E-01 |
| Stage1-vs-Stage3 |
8.425200E-01 |
| Stage1-vs-Stage4 |
5.122400E-01 |
| Stage2-vs-Stage3 |
5.543800E-01 |
| Stage2-vs-Stage4 |
7.917600E-01 |
| Stage3-vs-Stage4 |
6.926000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.535600E-02 |
| Normal-vs-AfricanAmerican |
4.960200E-01 |
| Normal-vs-Asian |
5.446400E-01 |
| Caucasian-vs-AfricanAmerican |
9.195800E-02 |
| Caucasian-vs-Asian |
4.584000E-01 |
| AfricanAmerican-vs-Asian |
2.916400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.446500E-02 |
| Normal-vs-Female |
6.482100E-02 |
| Male-vs-Female |
3.980800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.343570E-01 |
| Normal-vs-Age(41-60Yrs) |
1.079390E-01 |
| Normal-vs-Age(61-80Yrs) |
7.783800E-03 |
| Normal-vs-Age(81-100Yrs) |
9.510800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.850800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.454350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.568800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.464030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.599800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.563000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.167600E-02 |
| Classical-VS-Follicular |
1.77155999999679E-05 |
| Classical-VS-Other |
3.460800E-01 |
| Classical-VS-Normal |
6.505600E-01 |
| Tall-VS-Follicular |
8.996300E-02 |
| Tall-VS-Other |
7.297200E-01 |
| Tall-VS-Normal |
3.220400E-02 |
| Follicular-VS-Other |
7.750800E-01 |
| Follicular-VS-Normal |
7.97410000000776E-05 |
| Other-VS-Normal |
3.018600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.873900E-02 |
| Normal-vs-N1 |
2.880600E-03 |
| N0-vs-N1 |
1.808620E-01 |
|
|
